Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The combination of pregabalin and dexmedetomidine is used primarily for pain management, particularly in perioperative settings. This combination leverages the complementary mechanisms of both drugs to provide enhanced pain relief while potentially reducing side effects compared to higher doses of either medication alone. ## Pharmacology **Pregabalin** is a GABA analog that binds to the alpha-2-delta subgroup of calcium channels, reducing excitatory neurotransmitter release and preventing hyperalgesia and central sensitization[9]. It's primarily indicated for neuropathic pain, fibromyalgia, and as an adjunctive therapy for partial-onset seizures[5]. **Dexmedetomidine** is a highly selective alpha-2 adrenergic receptor agonist with a receptor selectivity (α2/α1) of 1,620:1[8]. It provides sedation, anxiolysis, and analgesia without significant respiratory depression. Its mechanism of action includes: 1. Peripheral analgesic effects by inhibiting pain signal transmission through Aδ and C fibers 2. Central analgesic effects by depolarizing the blue plaque and descending noradrenergic pathway 3. Local analgesic effects by modulating hyperalgesia through α2 receptor stimulation[8] ## Clinical Applications The combination of pregabalin and dexmedetomidine has been studied for several clinical applications: 1. **Postoperative Pain Management**: Studies have evaluated this combination for pain relief after total knee or hip arthroplasty[1][4][7]. The combination might reduce pain intensity on the visual analog scale (VAS) and decrease the volume of patient-controlled analgesia (PCA) containing morphine[7]. 2. **Hemodynamic Response Attenuation**: Research has compared the efficacy of pregabalin, dexmedetomidine, and their combination for attenuating hemodynamic stress responses during procedures like laparoscopic cholecystectomy[2]. 3. **Delirium Prevention**: The combination has been investigated for preventing delirium in elderly patients after cardiac surgery[9]. 4. **Sedation During Procedures**: Studies have assessed the effect of pregabalin premedication in conjunction with dexmedetomidine on sedation during cataract surgery[10]. ## Comparative Efficacy Interestingly, some research suggests that dexmedetomidine alone may be more effective than either pregabalin alone or the combination of pregabalin and dexmedetomidine in attenuating hemodynamic response to laryngoscopy[2]. However, the combination group showed significantly higher sedation scores in the preoperative period, reduced requirement of propofol, longer time for extubation and to respond to verbal commands after reversal, and lower pain scores compared to pregabalin alone[2]. The therapeutic efficacy of dexmedetomidine can be increased when used in combination with pregabalin[5], suggesting a potential synergistic effect that could allow for lower doses of each medication while maintaining efficacy. This combination represents an important approach in multimodal analgesia, potentially offering improved pain management with fewer side effects compared to traditional opioid-based regimens.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Pregabalin and Dexmedetomidine combination.